Global Cabazitaxel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cabazitaxel Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy.
Cabazitaxel report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cabazitaxel market is projected to reach US$ 293.4 million in 2034, increasing from US$ 203.5 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Age Below 65 and Age Above 65 are the major drivers for the industry.
USA is the largest Cabazitaxel market with about 95% market share. Europe is follower, accounting for about 3% market share.The key manufacturers are Sanofi, Tapi Teva, Fuan Pharmaceutical Group, Fujian Yewpark Biological etc. Top 3 companies occupied about 99% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cabazitaxel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
Segment by Type
Purity above 99%
Other Purity
Age Below 65
Age Above 65
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cabazitaxel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cabazitaxel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cabazitaxel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cabazitaxel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cabazitaxel introduction, etc. Cabazitaxel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cabazitaxel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Cabazitaxel report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cabazitaxel market is projected to reach US$ 293.4 million in 2034, increasing from US$ 203.5 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from Age Below 65 and Age Above 65 are the major drivers for the industry.
USA is the largest Cabazitaxel market with about 95% market share. Europe is follower, accounting for about 3% market share.The key manufacturers are Sanofi, Tapi Teva, Fuan Pharmaceutical Group, Fujian Yewpark Biological etc. Top 3 companies occupied about 99% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cabazitaxel market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
Tapi Teva
Fuan Pharmaceutical Group
Fujian Yewpark Biological
Segment by Type
Purity above 99%
Other Purity
Segment by Application
Age Below 65
Age Above 65
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cabazitaxel market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cabazitaxel, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cabazitaxel industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cabazitaxel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cabazitaxel introduction, etc. Cabazitaxel Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cabazitaxel market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices